Perfect storm for gene therapy?
Genome editing combined with stem cell generation could produce life extending therapies when boosted with big data
Join the club for FREE to access the whole archive and other member benefits.
Founder, Chairman and CEO at J. Craig Venter Institute and Author
J. Craig Venter, PhD, is regarded as one of the leading scientists of the 21st century for his numerous invaluable contributions to genomic research. Dr. Venter is Founder, Chairman, and CEO of the J. Craig Venter Institute (JCVI), a not-for-profit, research organization with approximately 200 scientists and staff dedicated to human, microbial, plant, synthetic and environmental genomic research, and the exploration of social and ethical issues in genomics.
Dr. Venter also is a co-founder of Synthetic Genomics, Inc. (SGI) and Human Longevity, Inc. (HLI). SGI is a privately held company developing products and solutions including sustainable bio-fuels, vaccines, biotherapeutics and transplantable organs. HLI is a genomic-based, health intelligence company empowering proactive healthcare.
Visit website: https://www.jcvi.org/about/jcventer
See also:
J. Craig Venter Institute (JCVI)
- Non-profit genomics research institute.
Genome editing combined with stem cell generation could produce life extending therapies when boosted with big data
Book about synthetic genomics written by J. Craig Venter
EurekAlert! - 27-Jan-2020
Made possible by early detection of disease and disease risks through whole genome sequencing
Read more...Business Wire - 27-Jan-2020
Studies were done by integrating whole-genome sequencing with advanced imaging and blood metabolites
Read more...Aging Reversed - 13-Jan-2017
The new approach to healthcare: proactive preventative personalised predictive Life threaten...
Read more...Fusion - 03-Mar-2016
They will not be old in mind or body, only in years. Likely to amplify economic inequality. Tho...
Read more...Sydney Morning Herald - 03-Oct-2015
If the greatest driver of disease in old age is old age itself, then why not find a cure for agei...
Read more...Next Big Future - 16-Jun-2015
HLI (Human Longevity Inc) has purchased two Illumina HiSeq X Ten Sequencing Systems to study inte...
Read more...Cosmos - 01-Jun-2015
Gains in US life expectancy mostly benefiting those with higher income. Income is the single big...
Read more...New Scientist - 01-Oct-2014
Rapamycin in mice The study was published in the Diabetes, Obesity and Metabolism journal.
Read more...